Have a personal or library account? Click to login
AKR1D1*36 C>T (rs1872930) allelic variant is associated with variability of the CYP2C9 genotype predicted pharmacokinetics of ibuprofen enantiomers – a pilot study in healthy volunteers Cover

AKR1D1*36 C>T (rs1872930) allelic variant is associated with variability of the CYP2C9 genotype predicted pharmacokinetics of ibuprofen enantiomers – a pilot study in healthy volunteers

Acta Pharmaceutica
Volume 69 (2019): Issue 3 (September 2019)
By: Aleksandra Kapedanovska Nestorovska,  Krume Jakjovski,  Zorica Naumovska,  Zoran Sterjev,  Nadica Matevska Geskovska,  Kristina Mladenovska,  Ljubica Suturkova and  Aleksandar Dimovski  
Open Access
|Jun 2019
DOI: https://doi.org/10.2478/acph-2019-0032 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 399 - 412
Accepted on: Feb 18, 2019
Published on: Jun 26, 2019
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
ibuprofen,
enantiomers,
pharmacokinetics,
AKR1D1,
CYP2C9,
pharmacogenetics
Related subjects:
Pharmacy,
Pharmacy, other

© 2019 Aleksandra Kapedanovska Nestorovska, Krume Jakjovski, Zorica Naumovska, Zoran Sterjev, Nadica Matevska Geskovska, Kristina Mladenovska, Ljubica Suturkova, Aleksandar Dimovski, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 69 (2019): Issue 3 (September 2019)Next article